ICMR Technologies available for collaboration  

  1. Diagnostic ELISA for detection of IgM antibodies against Dengue virus

  2. Diagnostic ELISA for detection of IgM antibodies against Japanese Encephalitis virus

  3. Diagnostic ELISA for detection of IgM antibodies against Chikungunya virus

  4. Evaluation of different delivery strategies for therapeutic applications of Klebsiella pneumoniae phages in burn wound model

  5. Diagnostic ELISA for detection of IgM antibodies against Chikungunya virus

  6. Diagnostic ELISA for detection of IgM antibodies against Japanese Encephalitis virus

  7. Diagnostic ELISA for detection of IgM antibodies against Dengue virus

  8. Co-immunization with HIV-1 Vaccinogens and immunomodulators

  9. Novel Immunogenic Antigens of Shigella

  10. HIV-1 Indian subtype C vaccine constructs for use in humans

  11. An anti-filarial composition

  12. A process for preparation of Holey/ Lacey films

  13. Macrofilaricidal composition for the treatment of filariasis

  14. Probes and primers for identification of Mycobacterial protein useful as potential drug targets

  15. A composition useful for identification of microorganism of interest

  16. Biocidal composition for controlling mosquito propagation

  17. Rare earth activated phosphor compounds and the process of preparation of phosphors thereof

  18. Superior and simple method to isolate very small embryonic-like stem cells (VSELs) without the Use of Flow Cytometry

  19. A novel Salmonella Typhi protein as subunit vaccine

  20. Measles IgM ELISA Kit

  21. Herbal formulation for treatment of Typhoid fever and preparation thereof

  22. Multiplex real time PCR testing kit for the simultaneous detection of hepatitis virus

  23. A compound, Transitmycin, effective against bacterial and viral pathogens

  24. Nano-engineered biodegradable polymer-composite for bone soft tissue fixation 

  25. Herbal Immersion Oil for Microscopy

  26. Improved process for the production of Cyclosporin A using the fungus Tolypocladium sp\

  27. Flyash based mosquito larvicidal formulations of Bacillus thuringiensis var. israelensis

  28. Fibrin wafer/disc as a biological carrier for sustained delivery of Curcumin

  29. Albuminated Curcumin for application in cancer therapy

  30. Neuro-Drill-Stencil-Trainer

  31. A box trainer for neuro-endoscopy

  32. A novel molecular diagnostic technique for detecting different species of Plasmodium

  33. A Thermoluminescent dosimeter by co-doping with Mn for measurement of low radiation doses 

  34. A PCR method for the detection of Chlamydia trachomatis

  35. A Novel Fumigation technique for antibacterial action

  36. An improved alcoholic composition derived from Tea and its method of preparation

  37. Novel Technology for Testing Water for Presence of Water-borne Viruses

  38. Anti- Crimean-Congo hemorrhagic fever (CCHF) Human IgM ELISA Kit

  39. Real-time RT-PCR Kit for Diagnosis of Kyasanur forest disease 

  40. Nested RT-PCR Kit for Diagnosis of Kyasanur forest disease

  41. Multiplex real time RT-PCR for Dengue and Chikungunya viruses

  42. Rota Virus Antigen capture ELISA

  43. A culture system for the growth of stem cells

  44.  Recombinant vaccine for Hepatitis E vaccine and combination of Hepatitis E & Hepatitis B vaccines using a novel approach.

  45. Dot ELISA for diagnosis of sequelae to Chlamydia trachomatis infection in women using chlamydial Heat Shock Protein-60.

  46. Species specific PCR assay for detection of L. donovani in clinical samples.

  47.  A cyclic lipopeptide of Bacillus subtilis ssp. subtilis (VCRC- B471) with potential to kill mosquito stages.

  48.  A process for diagnosis of infective (L3) stage larvae of Wuchereria bancrofti in vector mosquito Culex quinquefasciatus.

  49. B 426- A bacterial metabolite from Pseudomonas fluorescens showing pupicidal activity.

  50.  Mosquito larvicidal formulation from Bacillus thuringiensis var. israelensis.

  51.  PCR based diagnosis for visceral leishmaniasis from Urine samples.

  52. Novel noninvasive method for diagnosis of visceral leishmaniasis of sputum samples.

  53. Expanded Polystyrene beads (EPS) based application in Tamil Nadu rural sector as an adjunct to Mass Drug Administration (MDA) to reduce and sustain vector density and transmission rates in filariasis.

  54.  A cycle rickshaw based on ergonomic principles.

  55.  Formulations for prevention and therapy of sexually transmitted infection including HIV.

  56.  Multi-Angular Viewer for identification of mosquito species.

  57.  A herbal insecticidal composition.

  58.  Recombinant ELISA for the diagnosis of Leptospirosis.

  59.  A process for pot staining of sputum for detection of Acid fast Bacilli.

  60.  ELISA for Rotavirus.

  61.  PCR Methodology in Pathogen detection.

  62. Novel Primers for a PCR-RFLP assay for identification of species-specific pathogenic   Mycobacterium.

  63. Diagnostics kit for common beta thalassemia mutations.

  64.  Latex based diagnostics for Leptospirosis.

  65. Development of LAMP Assay for Diagnosis of Human Malaria.

  66. Diagnostic test for Chlamydia trachomatis.

  67. Monoclonal antibody for Chlamydia trachomatis.

  68. Plant’s extracts as replacement of fetal calf serum/ Blood/ Blood products free media for propagation of Leishmania parasites.

  69. An assay for detection of nucleotide substitutions in genomes of sabin oral poliovirus vaccine viruses.

  70.  Loop mediated isothermal amplification (LAMP) assay for a reliable and rapid diagnosis of Leishmania infection.

  71. An herbal hypoglycemic compound for controlling diabetes.

  72. Low Cost Point of Care Device for the Detection of Blood Glucose

  73. A device for visualizing the precancerous and cancer lesions of uterine cervix and oral cavity

  74. ELISA for Ferritin as marker for assessing bioavilability of iron using Caco-2 cell

  75. Dried Blood spot (DBS) -collection kit for sub-clinical deficiency of Vitamin A

  76. Personal cooling garment system

  77. Test/ Reagents for lung fluke useful for differential diagnosis from lung TB

         Details of the technology are listed in the attachment. Interested companies/ manufacturers may send their expression of interest to ICMR for further developing the technology along with the detailed proposal for the technology  providing detailed information as per the enclosed essential and desirable criteria to following;

Contact Address:  

Dr. Sadhana Srivastava

Scientist E, TRC/IPR Unit

Indian Council of Medical Research

Department of Health Research

(Ministry of Health & Family Welfare)

Ansari Nagar, New Delhi – 110029 

Cc: Shri T. Ramani

Sr. Administrative Officer

Division of P & I, Room No: 206

Indian Council of Medical Research (ICMR)

P.O. Box No: 4911, Ansari Nagar

New Delhi- 110 029

 

 

Home Page